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There has been much research done on the genetics of aging, but most of it is unavailable to a nonscientific audience.  
As a consequence, many people may not be aware that the knowledge and biotechnology exists today to lengthen lifespan 
in a variety of organisms, including humans.  
This paper offers a semi-technical review of what we currently know about the mechanisms behind aging.  Aging can 
be properly defined as a degenerative genetic disease.  If left untreated, it will lead to 100% mortality within 122 years of 
birth (the maximum known human lifespan).  It is not a natural process as many of us have come to believe.  Instead, this 
widespread disease is a result of 1) our own genetics, 2) instabilities in our DNA provoked by environmental causes, 3) 
accumulation of non-recyclable cellular byproducts, and 4) accumulation of cells that have senesced due to a combination 




of the above factors.  Aging should not go untreated now that we know of many genes that control this process, as well as 
genes that seem to treat its symptoms.   
Today there are non-cancerous cells from many organisms, including humans, that are normal in every respect except 
that they do not age.  Some examples of these otherwise normal, “immortal” cells are included in this paper.  They have 
enjoyed extensions of at least 3 times normal lifespan and may perhaps live even longer.  These cells have only simple 
genetic alterations.  They are living proof that it is possible to postpone the aging process via genetic manipulation. 
At this moment, researchers have the tools and experience to extend lifespan on a cellular level.  Could it be done in 
whole organisms with current techniques in gene therapy?  We don’t know because the research has yet to be done.  This 
research in animals and humans has such great promise of extending healthy, useful life that it seems incomprehensible that 
so few researchers are committed full-time to the genetics of aging.  One obstacle could be the lack of enough funding; 
another could be the lack of a convincing research proposal on how to lengthen lifespan.  The conclusion of this paper 
attempts to present such a proposal, involving current and reliable biotechnology.  There is also one last obstacle, the most 
important to consider.   
  
The Ethics of Extending Lifespan 
 
When a generation becomes the first to do something never before done in nature, there are often many unanswered 
questions.  The foremost of these is “Should we?”  Should we build airplanes, because if we were intended to fly we would 
have been given wings?  Should we use our resources to explore Mars so we can learn more about our origins, or improve 
living conditions on our current planet?  Should we genetically alter foods so fewer resources can be used to feed more 
people in our already overpopulated world, without doing anything else to make their lives more comfortable? 
As you are reading this today, the question is once again, “Should we?”  With the molecular tools and understanding 
available for the first time, should we try to extend the useful, disease-free lives of our species?  Should we attempt to 
postpone the “natural” process of dying?  What if people live longer but birth rates don’t decline—won’t the extra pollution 
and resource use this negatively affect our environment?  Will this technology be available to all people or the select few 
who can pay copiously for it?  There will undoubtedly be people who do not think we should tinker with nature, or who 
believe that trying to postpone death is futile.  It should be known that aging is not the norm for all forms of life.  For us, it 
is a degenerative disease that carries 100% mortality, and people with it deserve treatment as with any other serious disease.  




I want to learn to use the tools of genetics and molecular biology so I can eventually work toward extending life in some 
organism, whether it be a simple eukaryote, mice, or humans.  This is why I am applying to graduate school.  I may not 
have worked in a genetics lab but I have done my reading, as I hope to demonstrate with this paper.  I know about current 
research.  I know about the tools currently available.  Now I would like the opportunity to learn how to use them.   
As a human being, I have a choice just as you do.  I can live out my life until I die, like every other human being has 
since the beginning of our species, or I can try to take advantage of today’s tools and change things for everyone.  Someone 
once said a person hasn’t lived until he or she has found something worth dying for.  Well, we will all die anyway, but how 
many of us have found something worth living for?  It is important for me to at least try to do something.  Nobody wants to 
watch helplessly as loved ones deteriorate and die from a treatable disease.  However, few people seem willing to work 
through 5 years of graduate school to learn the science and technology that will enable them to realistically help.   
My wish is to see the future, in the company of those I care about and love.  I am curious how our species will decide to 
do things a hundred years from now.  Where will our free will and desire to live better take us?  How will we have 
changed?  Will we have learned to live in balance with the environment?  Will we have learned that wars are not solutions 
to problems, but the source of problems?  It is my curiosity that makes me desire to experience the next day, whether it be a 
good or bad one.  What other creature can experience a day as we can, or work to find ways to ensure more such days can 
be experienced?   
This is a fruitful dream worth passing along to others, a dream of someday being able to exceed our biological 
programming.  Every new bit of research makes that day of freedom draw closer, every voice of support, every eager 
student who wants to learn how to make this dream a reality. 
 




The Genetics of Aging 
What is Senescence? 
Senescence is the process by which a cell stops dividing and assumes an altered state of protein production.  A cell 
gradually ages until it reaches senescence.  Technically, senescence is an indefinite block to the cell cycle and further 
replication.  The cell cycle usually arrests at the G1-S phase transition, before new DNA synthesis occurs, but can also 
arrest at the G2-M transition before mitosis.1  The arrest is a sign that something has gone terribly wrong in the cell so that 
it cannot replicate, but not wrong enough that apoptosis is triggered.   
In vitro, this block to replication can occur in dividing cells by activating either the telomere-dependent (replicative 
senescence) or telomere-independent (cellular senescence) pathways.  Replicative senescence can be halted simply by 
forcing the expression of the hTERT gene to restore the function of telomerase, an enzyme that maintains the ends of 
chromosomes.  Cellular senescence, however, has a more complex cause resulting from widespread oxidative damage.   
In the absence of cell division, cells can still be induced into a senescence-like state by exposure to a fairly wide range 
of environmental stimuli, such as ectopic expression of RAS-V12 and ceramide treatment.2 
 
Regardless of how they are generated, all senescent 
states involve genome-wide transcriptional changes in 
the arrested cell, resulting in a dramatically different 
phenotype from its previous state (Table 1, right).  
Senescent cells exhibit multiple changes in gene 
expression, including down-regulation of cell cycle and 
stress response genes, and up-regulation of matrix-
remodeling proteins.3  This complex phenotype 
suggests that high-order changes in chromatin structure 
may be involved in the generation of the senescent 
phenotype.  This altered phenotype also negatively 
affects the tissue microbalance.  Senescent fibroblasts, 
for example, secrete proteases, anti-angiogenic factors, 
growth factors, and inflammatory cytokines, all of 
which are molecules that can be detrimental if not 
controlled.  Thus, the mere presence of senescent cells 
contributes to the aging of tissue.4 
 
Replicative and Cellular Senescence 
 
In replicative senescence, the gradual attrition of telomeres eventually leads to enough of a shortening to trigger a p53 
and p21waf-mediated cell cycle arrest.  The attrition can be caused by end-replication loss alone, or what is more likely in 
vivo, end-replication loss accompanied by additional telomere loss due to oxidative damage.  Evidence for this comes from 
the replicative immortalization of several different presenescent cell types by forcing them to express hTERT, the catalytic 
subunit of telomerase.5   
In cellular senescence, ectopic expression of hTERT alone is not sufficient for immortalization.  Instead, p16INK4A, an 
inhibitor of CDK 4-cyclin D and CDK6-cyclin E kinase pairs which can be upregulated by a wide variety of stimuli 
including senescence-causing genes, becomes overexpressed, which leads to the hypophosphorylation of retinoblastoma 
protein pRB.6 
Interestingly, neither of these two mechanisms appears to be responsible for cellular senescence in rodents.  Rodents are 
short-lived animals that die of cancer instead of old age.  A possible cause appears to be a telomere-independent but p53-
dependent mechanism caused by the p19arf gene product, possibly resulting from chronic oxidative stress in culture.7  
 
Senescence and Tumor Suppression Genes 
 
Senescence is mediated by CDK inhibitors, and controlled by the two most important tumor suppressor genes – p53 and 
pRB (retinoblastoma gene).  p53 is a transcription factor known to mediate a G1 arrest in response to DNA damage. The 
nuclear protein pRB controls the expression of other genes and halts the cell cycle in response to supermitogenic signals, 
damage, or oncogenes.  Oncogenes act by allowing cells to bypass the senescence response – they give cells a continuous 
“go” signal to divide regardless of any unrepaired DNA or structural damage that might exist. 




All senescent states somehow involve the p16Ink4a/pRb tumor suppression pathway.  p16Ink4a is one key link between 
cellular senescence and cell cycle regulation, and is often mutated or inactivated in normal-appearing and cancerous 
immortal cells.8 The p53 gene, if mutated to resemble active p53, gives enhanced tumor suppression but also symptoms of 
early aging.9 
Both p53-dependent and p53-independent pathways may exist to control the G1-S cell cycle transition.10 In human 
diploid fibroblasts, multiple targets have been identified downstream of p53--p2111, Gadd45, Mdm2, and cyclin G. p21 has 
been shown to potently inhibit CDK2,4-cyclin-A,E-kinase activity.12 Gamma irradiation of human diploid fibroblasts leads 
to induction of p53 and p21 and a G1 block. Interestingly, these cells show morphological changes reminiscent of cellular 
senescence13, and p21 was shown to be upregulated in senescent human fibroblasts.14 
Comparing Senescence Across Species 
 
Senescence is a universal feature in metazoans.  In plants, more than 30 senescence-associated genes have been found, 
though their senescence is regulated and not passive and time-dependent as in animals.15  As in animals, senescence in 
plants is triggered in times of stress, as when exposed to UV-C or pathogens.16  Fungi appear to be an exception—most 
fungi are potentially immortal.17  All natural Podospora isolates senesce, but most Neurospora isolates are immortal, 
though 40% of a strain of Neurospora in Hawaii carry a senescence plasmid and therefore senesce. 
Animals and plants senesce, and some fungi also senesce.  How far back in the evolutionary tree might senescence be 
traceable?  If senescence occurs in all eukaryotes, then perhaps there is something special about the eukaryotic condition 
that has necessitated senescence.  There is no senescence in prokaryotes.  Being single-celled versus multi-celled also has 
no bearing over whether an organism has senescence, since yeast are unicellular and still senesce. 
The differences between prokaryotes and eukaryotes are many.  All eukaryotes have mitochondria, while not all 
eukaryotes have chloroplasts.  We will see later that much of the structural degradation in plant chloroplasts is very similar 
to the degradation observed in animal mitochondria, which may prove to be an interesting focus of research.  Eukaryotes 
have an end-replication problem with their chromosomes because unlike prokaryotes, they lack circular chromosomes.  
Finally, eukaryotes also have membrane-bound organelles, which means that cellular ingredients are compartmentalized, 
and their transportation strongly depends on membrane composition and integrity.   
The smallest known eukaryote, a microsporidian called Encephalitozoon cuniculi, is an intracellular parasite of 
eukaryotic cells.18  Its genome is less than 3 Mb in length, which is more than 1000 times smaller than the human genome.  
Its genes are also 20-30% smaller than homologous eukaryotic or bacterial genes.  Its genome has been pared down through 
evolution to contain only those genes necessary for its parasitic lifestyle.  It would be interesting to learn whether this tiny 
fungus also possesses senescence.  If so, the mechanism(s) by which it senesces should be very simple to study, compared 
to organisms with larger genomes.   
Genes Governing Cellular Senescence 
 
Cellular senescence is controlled by a highly specific set of genes in a pathway.  Turn off any of these genes and the cell 
will become immortal.  This can be done by deleting one of the genes through mutation, or by adding one of its repressors.  
Cancerous and “normal” immortal cell lines, for example, often have an additional part of a chromosome (6p or 8q in 
normal immortal cell lines) that likely encodes for a repressor of one of these senescence genes. 
The senescence genes all appear to be of dominant inheritance with high levels of homozygosity; otherwise there would 
be substantial populations of immortal cells within organisms.  The repressors of these genes may be turned off early in 
development by other repressors or cannot function as senescence repressors in low concentration.  If chromosome 6p or 8q 
encodes one or more senescence repressors, this would explain why adding them to a cell line can make it immortal. 
Complementation tests were done between 30 different immortal cell lines to identify senescence-related genes.19  Four 
complementation groups emerged (Groups A-D), and the chromosomes containing these senescence genes have largely 
been discovered.  The possibility exists that there could be more than one senescence gene on the following chromosomes.   
 
• The Group A gene is on an undiscovered chromosome.  
• Chromosome 1q contains the Group C gene.20  
• Chromosome 7 contains a gene that inhibits the ALT pathway that maintains telomere length; adding it to 
immortal cells missing it (Group D) kills the ALT pathway.21   
• Chromosome 4 contains the MORF4 gene at 4q33-3422. Adding it to immortal cells missing it (Group B) restores 
senescence.23  
 
There are 6 MORF-related genes.24  Only MRG15 on chromosome 15 and MRX on chromosome X are expressed; the 
others are pseudogenes.  MRG15 and MRGX may be involved in transcriptional complexes that effect global changes in 




gene expression.  MORF4 can disrupt these complexes by acting in a dominant negative manner, thereby inducing 
senescence.  MORF4, MRG15, and MRGX are highly conserved in the 3’ region of the gene. They all have nuclear 
localization signals, helix–loop helix and leucine zipper regions, and phosphorylation sites. MRG15 has an additional 5’ 
region that encodes a chromodomain, while MRGX has a unique 5’ region.  
Chromosome 3 encodes a repressor of telomerase, at least in the human breast carcinoma cell line 21NT.25  Senescence 
may be induced through telomere length regulation. Chromosome 3 produces telomerase suppression much like 
Chromosome 4.26   
From the above findings and what we have learned from the genetic variations in “normal” immortal cell lines (to be 
discussed shortly), immortalization can be achieved by either: 
 
• deleting/turning off any one of the above senescence genes: MORF4 (chromosome 4), a gene on chromosome 1q, 
a gene inhibiting the ALT pathway on chromosome 7, and a non-located Group A gene, or 
 
• adding a gene or genes on either 6p or 8q; some i(6p) cells later develop i(8q) and +7, while some i(8q) cells later 
develop i(1q) and a marker chromosome. 
 
Chromosomes 2, 3, 6q, 11, 18, and X have also been implicated in causing senescence in specific immortal cell lines, 
though the observed senescence could be due to a dosage effect and not a true genetic event.27 
Human chromosome 7 causes senescence in Group D cell lines, which have unusually long telomeric sequences but no 
detectable telomerase activity.  In the transfected cells, the telomeres were lost or markedly diminished, but were not altered 
significantly in non-transfected cells.  This suggests that telomere length in these Group D cells are maintained through the 
ALT pathway, and that chromosome 7 may encode an inhibitor of this pathway.28  
 
Normal Immortal Cells 
 
The following three cell lines are unique in that they do not senesce and die, but also are not cancerous.  In fact, tests 
show that they have rather normal phenotypes, and require the same growth factors as normal cells.  They are currently 
being used for studies of skin replacement and cancer, but it would be another burgeoning area of research to study 
them for what they are, normal cells that have genetically circumvented the aging process. 
These three cell lines are all human fibroblasts, epithelial cells that are an important component of the skin.  As 
such, they are routinely subjected to some amount of physical and oxidative environmental stress.  A single person is 
likely to have a range of cell damage amounts in their fibroblasts because some areas of skin may be subjected to 
photoaging, pressure, and rubbing, while others will not.  If this range of fibroblasts can be made immortal 
experimentally by inactivating senescence genes, it may be possible to understand how these senescence genes interact 
with other genes to bring about the senescent phenotype.  Changes in a senescing cell begin well before the cell actually 
stops dividing, and for this process to be understood, cells at different stages of their replicative lifespan must be 
studied.  DNA microarrays would be useful to give a broad look at how gene expression changes within a cell during 
the immortalization process.   
Making these cells immortal will turn off the senescence mechanism, but not necessarily erase the damage and other 
effects that aging has had on the cell.  It would be interesting to know whether immortalizing cells late in their 
replicative lifespan predisposes them to cancer.  
Individual human cells have naturally reached immortality without becoming cancerous.  This raises the possibility 
that other non-fibroblast cells, and perhaps even entire organisms, may be able to do the same.  If replicative 
immortality is a matter of switching off senescence genes or turning on their repressors by transfection, then what if this 
were done in a developing zygote of, say, yeast cells, C. elegans, or the fruit fly?  Would the organism be able to 
develop normally with any one or more of its senescence genes switched off?  If not, we would know that these genes 
also play a major role in the development of at least lower eukaryotes.  If development proceeds normally, the resulting 
adult organism would lack a complete senescence pathway in all its cells, and therefore the organism as a whole should 
exhibit replicative immortality. 
This would be indeed interesting, since cells that have reached replicative immortality have shown lifespan 
extensions of at least 3 times normal lifespan.  Things may be different in an organism that has reached replicative 
immortality, but significant lifespan extension is still a real possibility. However, it is important to note that the 
organism would likely not reach a complete cellular immortality, as oxidative damage would eventually cause so much 
irreversible chaos to cell components that senescence would be triggered by alternative pathways.  This is assuming that 
cancer does not develop before cellular senescence is reached.  Still, if an organism has replicative immortality, it 
should exceed its normal lifespan because senescent cells are not changing their microenvironment and accelerating 




age-related damage in the process.  This is seen in current immortal cell lines, none of which senesce.  With this factor 
contributing to death removed, organisms with replicative immortality should succumb instead to the changes caused by 
oxidative damage.  The onset of cancer and oxidative damage-induced senescence could be postponed by boosting 
antioxidant and DNA repair systems. 
SIK 
SIK stands for “spontaneously immortalized keratinocytes.”  In the original cultures, cells were of normal karyotype 
and formed colonies with an efficiency of ~3% through 10 passages.  At passage 15, after normal strains senesce, the 
colony forming efficiency of this cell line increased, stabilizing at ~30% by passage 40.  Something must have caused 
this approximately tenfold increase in colony forming efficiency and nearly 3 times extension of replicative lifespan.29   
During the increase in colony forming efficiency, cells acquired an extra isochromosome 6p, and showed 5-10 fold 
increases in expression of cell cycle control proteins cyclin A, cyclin B, and p34cdc2.  At later passages, cells also 
showed i(8q) and +7, but the i(6p) and increased cell-cycle protein expression remained.  These latter features were 
probably important for immortalization.  Like normal, non-cancerous keratinocytes, the SIK cells were sensitive to 
growth suppression by TGF-B and tetradecanoylphorbol acetate, and depend on epidermal growth factor (EGF) for 
progressive growth. 
These results indicate that normal, limited lifespan is the dominant inherited trait, regardless of cell type.  Therefore, 
immortal cells must have a recessive gene for that trait.  Any of 30 immortal cell lines have been shown to fit into one 
of 4 possible complementation groups, which suggests that a small number of highly specific genes are involved in 
senescence.  This set of genes must be turned on for a cell to become senescent, but losing any one of the set will render 
the cell immortal.   
Chromosome 11 is implicated in tumor suppression, but when added to these immortal cell lines, nothing happened.  
The tumor suppressor gene(s) on Chromosome 11 may stop tumors, but are not involved in the aging process.  
Chromosome 4 induced senescence in a line of cervical carcinoma cells, but not in other groups.  It is not known 
whether these cancer cells may have shared features with complementation group B, for which MORF4 on 
Chromosome 4 induces senescence. 
NIKS 
The NIKS cell line has been patented as ATCC CRL-12191 (previously called BC-1-Ep/SL cells).30  They show a 
normal karyotype of 46 chromosomes, except with i(8q).  Like normal keratinocytes, they need epidermal growth factor 
(EGF) for serial passage.  They can survive without it, but grow poorly.31  TGF-beta 1 also inhibits growth.  At passage 
17, only NIKS cells remained in the culture.  At passage 31, all cells had i(8q) only.  At passage 54, all cells still had 




NM1 is a human keratinocyte line that is trisomic for chromosome 8 and also XY as the NIKS cell line.32  Being 
trisomic for chromosome 8, it shares the expression of extra 8q genes with the NIKS cell line, and suggests that the 
expression of extra 8p genes does not affect immortality.  These cells differ from NIKS in that they can be grown 







Telomeres are regions of repetitive DNA that cap the ends of chromosomes, preventing loss of vital genetic 
information when cells divide.  Telomeres are presumably an adaptation evolved by eukaryotes who, unlike their 
prokaryotic ancestors, had to replicate linear instead of circular chromosomes.   
There is a consistent shortening of telomeres during cellular aging.  Human telomeres shorten by about 100 bp per 
cell division.  When several kb of telomeric DNA are lost, this triggers the cell to undergo senescence.  An interesting 
line of research lies in understanding how this triggering occurs, since it is presently unknown.  It is not that senescent 




human cells have lost all their telomeric DNA; they carry residual telomeres similar in length to those of many other 
eukaryotes. 
A hypothesis for how telomeric loss triggers senescence deals with the formation of abnormal chromosome 
structures called dicentric and ring chromosomes.33  These structures have been observed at senescence at a relatively 
high frequency (30-70%), when a critical telomere length has been reached.  It has been proposed that the loss of 
telomeric DNA from any chromosome generates dicentric and ring chromosomes.  These unstable structures break 
during the next mitotic event, signaling a DNA damage pathway that ends with G1 cell cycle arrest and senescence. The 
frequency of dicentric chromosomes dramatically rises near senescence and coincides with p53 protein activation, 
suggesting that the formation and breakage of dicentric chromosomes activates p53.  As mentioned earlier, senescence 
is mediated by p53 activity.34 
 
In animals, long-lived species often 
have shorter telomeres than short-lived 
species, indicating that telomere length 
probably doesn’t determine lifespan.  
Mice, for example, have telomeres 3 times 
longer than ours, yet its cells do not live 3 
times as long.  However, older people do 
have shorter telomeres than younger 
people. 
Perhaps the observation that longer-
lived species often have shorter telomeres 
than shorter-lived species results from 
better antioxidant mechanisms in longer-
lived species, allowing them to achieve a 
longer life.  Therefore, the telomeres don’t 
get shortened as much in longer-lived 
species as they would in shorter-lived 
species with poorer antioxidant 
mechanisms.  That might be why shorter-
lived species have longer telomeres, to buy 
more time before oxidative damage 
provokes senescence. 
The size of the telomeric G-rich 3’ 
overhang is longer in cell strains whose 
telomeres shorten more rapidly in culture.  
This implies that end-processing events 
might be manipulable to slow the rate of 




Composition of Telomerase 
 
Telomerase is a ribonucleoprotein with reverse transcriptase activity.  It works by adding TTAGGG repeats directly 
to the G-rich 3’ overhang, thus extending the length of telomeres.  The catalytic subunit of human telomerase is called 
hTERT, which has reverse transcriptase activity.35  hTERT is located at chromosome 5p15.33.36 The RNA component 
of telomerase is encoded by hTR, human telomerase RNA, and is where the sequence complementary to TTAGGG 
resides.  It is located at chromosome 3q21-q28.37  A mammalian protein that is associated with telomerase, TP1, can be 
found at chromosome 14q11.2.38 
 
Telomerase and Senescence 
 
Telomerase protects against replicative, but not other forms of cellular senescence (DNA damage, oncogenes, etc.).  
It preferentially elongates the shortest telomeres, and it is the shortest telomeres, not average telomere length, that limits 
From Dr. Katherine Friedman’s Lab, Vanderbilt University 
http://www.molbio.vanderbilt.edu/mbdept/faculty/friedman.html 




proliferation.  This supports the interpretation that DNA damage signals rather than telomere positional effects induce 
the senescent growth arrest. 
The telomeres of somatic cells are significantly shorter than in germline cells.  This is because the enzyme 
telomerase, which acts to lengthen the telomeres, is active in germline and stem cells.  Without this enzyme, these cells 
would also senesce. 
 
Telomerase and Immortalization 
 
Since most somatic human cells do not express the reverse transcriptase but contain all other enzymatic components 
for telomerase, forcing the expression of the missing hTERT can reconstitute enzyme activity.39  This was done in an 
experiment where human cells were transfected with the hTERT gene.  As a result, the newly reconstituted telomerase 
lengthened telomeres with additional TTAGGG repeats.  Many transfected cell lines proceeded for 20 population 
doublings beyond their normal senescence point, grew vigorously, and showed a normal karyotype and youthful 
morphology.  They continued to exhibit normal checkpoint controls, could be growth arrested by the overexpression of 
oncogenes like H-ras, and did not form tumors. This outcome occurred in retinal epithelial cells, foreskin fibroblasts, 
and vascular endothelial cells.40  
In epidermal keratinocytes and mammary, adenoid, thyroid, and prostate epithelial cells, telomerase is insufficient 
for immortalization.  Inactivation of the p16/pRB pathway by methylation of the p16 gene or expression of viral 
oncogenes like human papilloma virus protein E7 is also required.  However, many of these cells are grown in a 
chemically-defined medium and not on feeder layers.  If grown on feeder layers, they can be immortalized by 
telomerase without inactivating p16.  Thus, the medium matters.  If an immortal cell line can grow without a feeder 
layer, perhaps it has the p16/pRB pathway or something like it inactivated. 
 
Telomerase and Cancer 
 
Telomerase is turned off in most human tissues during development, except for germline and stem cells.  One or 
more tumor suppressor genes may prevent activation of telomerase in normal human cells.  To become immortal, cells 
must undergo a crucial change in telomere dynamics.  They must either activate telomerase or an alternative mechanism 
that maintains telomeric DNA (ALT pathway).  This is necessary for an immortal phenotype because without telomere 
maintenance, replicative senescence would eventually occur. 
We have seen that the forced expression of telomerase can create immortal but otherwise normal, non-tumorigenic 
cells.  To form a tumor, at least 3 additional functions are required: H-ras to activate autonomous cell division, SV40 
large T antigen to block pRB and p53 checkpoint/apoptotic mechanisms, and SV40 small t antigen to inhibit 
phosphatase activity. 
Tumors also have much higher telomerase activity than that occurring normally in stem cells.  Telomerase is usually 
sequestered after cell division, but in cancer cells, telomerase is often present throughout the cell, all the time. 
 
Oxidative Damage 
Mitochondria and Oxidative Damage 
 
Mitochondria are the sites of ATP production through the process of oxidative phosphorylation.  Because of the 
oxidative, energy-yielding set of reactions required to make ATP, they are also an important source of reactive oxygen 
species and other free radicals.  Since these reactive byproducts of cellular respiration are produced so close to the 
mitochondria, the mitochondria have a much greater likelihood of being damaged by these byproducts than other 
cellular components.  Their DNA consists of circular strands of 16,569 nucleic acids that code for 13 proteins.  Because 
many mitochondrial genes have been lost or relocated to the nucleus over the course of evolution, the mitochondria 
have poorer DNA repair capabilities than the nucleus.  This compounds the problem of increased damage to this 
important organelle. 
Cells have multiple protective mechanisms, and can prevent damage if the oxidative stress is not too great.  
However, any imbalance between pro-oxidant and anti-oxidant systems can lead to oxidative damage.  Free radicals can 
damage the mitochondrial membranes, proteins, and DNA, leading to decreased energy-producing efficiency over time.  
In addition, damage to DNA repair and antioxidant genes hampers their ability to function.  Oxidative damage to genes 
will go unrepaired and free radicals will go unquenched.  These in turn will cause more damage to DNA repair and 
antioxidant genes.  It is a vicious cycle, and one that contributes greatly to the aging process.   




Oxidative damage is the main source of mutation and structural degradation in cells.  Reactive oxygen species can 
diffuse rather far from their site of formation, whether they were made in the mitochondria or other sources such as 
oxidases in the cytoplasm.  Without enhancing DNA repair and antioxidant machinery, even replicatively immortal cells 
will eventually succumb to oxidative damage.  Simply turning on telomerase is not a cure-all for aging.  Even with 
much improved DNA repair and antioxidant systems, some free radicals will undoubtedly escape to create non-
recyclable byproducts that will accumulate within the cell, hampering its function.  Thus, it is certainly possible today to 
extend life by manipulating genes, but without more advanced tools that are only in the earliest stages of development 
(e.g. nanotechnology), it will not be possible today to extend life indefinitely. 
 
Mitochondrial Retrograde Response and Lifespan 
 
Nuclear gene expression can be modulated by changes in the functional state of mitochondria.  This modulation 
takes place through a communication pathway between the two organelles called the retrograde response.  This 
retrograde signaling pathway functions as a homeostatic or stress response mechanism to adjust various biosynthetic 
and metabolic activities to changes in mitochondrial activity.41   
Of special importance are changes in the expression of senescence or lifespan-extending genes via the retrograde 
response.  The products of three yeast genes RTG1, RTG2, and RTG3 are expressed in yeast with defective 
mitochondria, which also happen to have increased longevity.  These genes signal the nucleus that the mitochondria are 
less than fully functional in the retrograde response.42 Adding antioxidants to the culture media do not increase their 
lifespan, which suggests that reduced oxidative damage is not the mechanism for life span extension in these cells. 
Instead, lifespan extension and delayed aging appears to be triggered by the products of the RTG genes, which trigger 
the retrograde response in the cell nucleus.
Free Radical Types 
 
There are five main types of free radicals, all with varying degrees of toxicity.  They are nitric oxide, peroxynitrite, 
hydrogen peroxide, superoxide anion, and the hydroxyl radical.  Of the five, hydroxyl radical is the most reactive.  All cells 
have some mechanisms of detoxifying these radicals and repairing the damage they cause.  It is only when the production 
of radicals exceed the cell’s capacity for detoxification that oxidative damage occurs, which unfortunately happens quite 
frequently. 
 
NO radical (nitric oxide) either reacts quickly with oxygen, or can react with superoxide anion to form the more 
reactive peroxynitrite, which can decompose to form a hydroxyl radical.  Peroxynitrite attacks protein cysteines, 
methionines, and tyrosines by adding an NO2 to the ring of these amino acids.  These protein modifications may explain the 
observed biological effects of this radical.  Nitric oxide is involved in smooth muscle relaxation, neurotransmission, and 
immune regulation.  However, elevated levels of nitric oxide can be toxic to DNA43 and may even cause cancer.44   
H2O2 (hydrogen peroxide) is a non-radical that can diffuse over considerable distances, and may pass membranes 
readily in the process. 
O2 radical (superoxide anion) is continuously generated by several cellular processes, including the microsomal and 
mitochondrial electron transport systems.  Oxidation processes involving cytochrome p450 and NADPH-cytochrome c 
reductase on the endoplasmic reticulum can generate superoxide anion and H2O2.  Xanthine dehydrogenase/oxidase and 
other cellular oxidases are also important sources.  Superoxide anion is not a particularly reactive molecule, and can diffuse 
considerable distances from its varied sites of production.  The superoxide dismutase enzyme (SOD) universally present in 
both cytoplasm and mitochondria ensures that much of this anion is rapidly converted to hydrogen peroxide and O2.   
In the presence of a transition cation like Fe or Cu, superoxide anion can give rise to the highly reactive hydroxyl 
radical species (HO.).  HO can react with biomolecules and produce products that cannot be regenerated by cell 
metabolism.  The hydroxyl radical reacts very close to its site of production, making its damage very site-specific. 
When HO reacts with nucleic acids, it modifies the bases.  Examples of HO base attack products are 8-
hydroxyguanosine, thymidine glycol, and uric acid.   
When HO reacts with proteins, they can be fragmented.  This fragmentation is associated with reactions at specific 
amino acids such as proline and histidine.  Proteins can also contain metal binding sites that are especially susceptible to 
oxidative events through interaction with the metals.  These reactions usually produce irreversible modifications in amino 
acids involved in metal ion binding (i.e. histidine), and may create signal sequences recognized by specific cellular 
proteases that degrade such proteins. 
Cysteines and methionines on intracellular proteins can be reversibly modified by radicals.  This serves a protective role 
since the radical is detoxified without causing harm.  Oxidation of proline, however, is irreversible.  The result of such 
oxidation is a break in the polypeptide chain and the introduction of new carboxyl groups. 







Lipid peroxidation is a radical-initiated chain reaction that self-propagates in cell membranes, occurring on unsaturated 
fatty acid chains that reside within the lipid bilayer.  It is mainly what causes rancidity in foods and decaying animals.  
Lipid peroxidation of polyunsaturated lipids occurs easily by reacting with hydroxyl radicals, which yield lipid radicals.  
When two lipid radicals meet, they can detoxify each other, but only by forming a covalent bond.  As a result, lipid radicals 
can seriously impair membrane function by making the membrane rigid and reactive to other biomolecules.   
The most commonly measured product of lipid peroxidation is malondialdehyde.  The unsaturated aldehydes produced 
by these reactions are implicated in modifying cellular proteins and other materials.45  A peroxidized lipid can produce 
peroxy radicals and singlet oxygen. 
Vitamin E, a lipophilic molecule, is a particularly effective antioxidant in biological membranes and lipid particles 
found in blood plasma.  However, it is not 100% effective, as is any antioxidant, from quenching all free radicals that might 
produce damage to cellular components. 
Oxidative Detoxification and DNA Repair 
 
These are the only two defenses cells have at their disposal for combating oxidative damage.  Antioxidants try to 
prevent the damage before it occurs, while DNA repair mechanisms try to fix the damage.  Neither are 100% effective, as 
endogenous and dietary antioxidants are not available at high enough concentrations to neutralize all free radicals.  The 
ones that escape will eventually cause some kind of irreversible damage to biomolecules.  Improving these systems and 
perhaps designing better antioxidants, such as one made at Stanford University that can localize itself to mitochondria 80 
times more effectively than vitamin E, will extend the time before oxidative damage triggers cellular senescence or cancer. 
 
Superoxide dismutase (SOD) neutralizes superoxide anion radicals by converting them to H2O2.  Catalase and 
glutathione peroxidase then neutralize the H2O2.  In Down’s syndrome, there are 3 copies of the SOD gene because it 
resides on chromosome 21.  With the overproduction of SOD, catalase and glutathione peroxidase can’t keep up with the 
accelerated production of H2O2.  The hydrogen peroxide thus accumulates in the cells, causing increased oxidative stress, 
free-radical proliferation, and accelerated aging.  An excess of SOD leads to the premature oxidation and death of brain 
cells.  The degeneration of neurons in Down’s cells has been shown to be preventable by applying antioxidants. 
SOD is present as a Cu-Zn enzyme in the cell cytoplasm, and as the Mn enzyme called MnSOD in the mitochondria.  It 
needs a Cu chaperone to cross the membrane.  The absence of SOD is lethal.  The amount of SOD in the cell is controlled 
by specific redox-sensitive genes.  There is also an extracellular form of SOD in plasma, lymph, and synovial fluid that 
differs from the intracellular form.  The extracellular enzyme may function at cell surfaces.   
Overexpression of MnSOD (also called SOD2), along with other forms of SOD has been shown to increase the lifespan 
of adult Drosophila melanogaster.46 However, MnSOD overexpression in yeast increases the chronological lifespan, but 
dramatically reduces replicative lifespan.  This could be due to the absence of adequate mechanisms in yeast mitochondria 
to deal with the increased H2O2 that more MnSOD would produce. 
Catalase is a heme protein that detoxifies H2O2.  It is usually found in peroxisomes except in cells like erythrocytes that 
don’t have them.  In that case, catalase is a cytoplasmic enzyme.  Catalase along with glutathione peroxidase, a cytoplasmic 
and mitochondrial enzyme, are important in detoxifying H2O2. 
Glutathione is a peptide made from the amino acids cysteine, glycine, and glutamic acid that detoxifies H2O2.  It is 
found at high intracellular concentrations and has high water solubility, and is the major antioxidant in much of the 
cytoplasm.   
 
Glycosylases, exonucleases, and endonucleases are among the group of enzymes that repair DNA.47 
How Oxidative Damage Affects Telomeres 
 
Hyperoxia can induce single-stranded breaks in the G-rich strand of telomeres, which are repaired much less efficiently 
than those elsewhere in the genome.  As a result, the telomeres shorten, and G-rich single-stranded DNA fragments begin to 
accumulate.  This accumulation of ssDNA due to telomere shortening triggers a p53-dependent cell cycle arrest. 
Reactive oxygen species have been shown to increase in concentration during the last 15 doublings of IMR90 lung 
fibroblasts in vitro.  This may explain observations that telomere shortening appears to be caused by oxidative damage 
during the last 15 doublings in similar cells.  The rate of shortening can be slowed by introducing antioxidants into the 
medium.   




Oxidative damage to telomeres produces breaks of random sizes and does not affect the size of the G-rich 3’ overhang.  
The rate of telomere loss in different cultured cell types is proportional to the size of this overhang, strongly suggesting that 
events at the end of the chromosome (the end-replication problem and processing mechanisms) are the primary determinant 
of the rate of telomere shortening. 
 
Cell Culture Medium and Damage 
 
Cell culture media can often induce DNA damage.  Proliferation has been shown to stop after only 3-4 doublings in 
mouse cells containing defects in a large variety of DNA repair functions, but since the animals are viable, they must be 
able to divide much more than 4 times in vivo.  Interestingly, mouse cells have been reported to be immortal and remain 
diploid if cultured in a special medium.48  
Maybe mice don’t have telomere-based replicative senescence, but culture-induced growth arrest instead.  Still, TBRS 
could have evolved in larger, longer-lived organisms as an additional restraint against tumor formation. 
 
Structural Degradation and Genetic Instability 
 
The first obvious cause of structural degradation is oxidative damage to biomolecules.  We have seen that reactive 
oxygen species can attack lipids, proteins, carbohydrates, and nucleic acids, causing the destabilization and dysfunction 
of cellular architecture.  Environmental causes of structural degradation such as high temperature, changes in the 
extracellular chemistry, and physical stress such as excessive movement or even pressure in the form of intense noise49 
can act by producing oxidative damage.  One other important cause of structural degradation is a change in the 
expression of genes that contribute to structural integrity. 
Structural degradation has a direct link to genetic instability, and thus to senescence.  Researchers at Duke 
University have found that genetic instability can be caused by stresses that do and do not directly damage DNA.50  For 
example, if the cytoskeleton supporting the nuclear membrane or nucleolus is compromised either by environmental 
stress, oxidative damage, or genetic causes, this will signal cell cycle arrest via CDK inhibitors, which will benefit the 
cell by preventing an otherwise problematic cell division.  This is because if spindle fibers cannot attach to the 
cytoskeleton properly, cell division will likely go awry.  Especially compelling evidence for a structural contribution to 
aging can be found in Werner’s syndrome and progeria.  Here, the loss of a gene that contributes to nucleolar or nuclear 
membrane structural integrity is responsible for rapid aging.  With poor structural integrity in the nucleus, cells in these 
patients are triggered to senesce much earlier than usual through the usual senescence pathways.  
It is quite interesting that senescing plant leaves exhibit many of the same structural changes as senescing animal 
cells.  As a plant or its leaves get older, the leaves show increasing photosynthetic rates (growth) until the time of 
flowering (reproduction), after which the rates fall off rapidly, regardless of the age of the individual leaf.  The aging of 
leaves is associated with an extended decline in the protein and chlorophyll content, an increase in leaf permeability, 
and an increase in the apparent free space of leaf tissues, which implies an increase in the leakiness of membranes in the 
leaf.  There is also structural deterioration of chloroplasts, and much later, the nuclear membrane.51   
Several sources cite genomic instability as a cause of aging instead of gene dysregulation.52  There is also much 
evidence that damaged proteins play a role in aging, and that overexpression of chaperones can extend lifespan.53 
Werner’s Syndrome: Degradation of the Nucleolus 
 
The nucleolus contains highly repeated copies of rDNA.  The repeated nature of this rDNA may make it less stable 
than the rest of the genome, and more vulnerable to the fragmentation seen in older cells.54  During cell reproduction the 
nucleolus disappears, but not all of its fragments may disappear, particularly the extrachromosomal rDNA circles 
(ERCs) formed by homologous recombination.  It is known that ERCs get replicated until they reaches toxic levels in 
old cells, but the mechanism of toxicity is not known.55  It is hypothesized that these fragments remain and hamper the 
formation of spindle fibers during mitosis, which may contribute to the greater risk of chromosomal abnormalities as 
cells age and accumulate ERCs.  Some proteins that localize themselves in the nucleolus may counteract homologous 
recombination, thus preventing the formation of mitosis-hampering ERCs.  WRN may be one such protein. 
WRN is the protein defective in Werner’s syndrome, a premature aging disorder that causes cataracts, osteoporosis, 
diabetes, and cancer at an early age.  The WRN gene product is located in the nucleolus, and has 3’-5’ helicase and 3’-
5’ exonuclease activities.56 57  It has been shown to be recruited by TRF2, a telomeric repeat binding factor, to facilitate 
the breakdown of telomeric fragments.58  TRF2 by itself stabilizes telomere ends by promoting the formation of stable T 
loops, prevents end-joining, and prevents the activation of cell checkpoint pathways that unprotected telomeric ends 




would cause.  Without WRN, unusual structures on telomeres cannot be degraded properly, which can cause 
senescence.  It is notable that the addition of telomerase can restore the lost telomere maintenance function of WRN and 
immortalize Werner’s cells. 
However, WRN may have other functions in the nucleus, as evidenced by its localization within the nucleolus.  The 
mouse homolog of WRN, mWRN, is present diffusely throughout the nucleus in mice instead of localized within the 
nucleolus.  Mice live shorter lifespans than humans (2 years vs. an average of 80 years), and appear to die of cancer 
rather than old age.59  This would seem to suggest that WRN interacts with nucleolar components in a way that extends 
lifespan. 
 
Certain genes in yeast determine lifespan, promoting cell longevity by moving from the telomeres to the nucleolus.  
The yeast longevity gene SGS1 corresponds structurally to human WRN.  Experimental mutation of SGS1 produced 
symptoms of aging in yeast, the foremost of which was fragmentation and enlargement of the nucleolus.  A mutation in 
SGS1 shortens yeast lifespan by ~60%, a striking parallel to Werner’s.  These results suggest that nucleolar 
fragmentation may be a cause of aging.  They do not specifically suggest that ERC formation might be the cause of this 
aging, so this would be another avenue of research.  It would seem, however, that nucleolar fragmentation and 
enlargement would be consistent with the accumulation of extrachromosomal rDNA circles.  Also, the preponderance of 
these and other non-recyclable cellular byproducts may contribute to the larger size of older, senescent cells compared 
with younger cells.   
It is interesting that SGS1 and WRN both move from the telomeres to the nucleolus.  This protein that normally 
resides on the telomeres must somehow be triggered to move to the nucleolus instead.  If the telomeres are deacetylated, 
as they would be if the histone deacetylase and known lifespan-extending enzyme SIR2 were active, the chromatin 
would condense near the telomeres.  This chromatin condensation may trigger the release of SGS1/WRN, perhaps 
because the substrates they normally attach to are no longer accessible or have already been released during chromatin 
condensation.  Without binding spots available at the telomeres, this protein would have a greater chance of being found 
in the nucleolus where it can suppress nucleolar fragmentation.   
Another line of research has shown that the concentration of WRN in the nucleolus remains constant in a variety of 
normal and cancerous human cells, indicating that the presence of other diseases does not disrupt WRN from its job.60 
Sir2 is also known to extend yeast lifespan by stabilizing repetitive DNA.61  Resveratrol was able to reduce the 
frequency of rDNA recombination by about 60% in a SIR2-dependent manner.   
Progeria: Degradation of the Nuclear Membrane 
 
Progeria is a premature aging disorder caused by a mutation in the lamin A gene (LMNA), which codes for a key 
component of the nuclear membrane.  LMNA is located at 1q21.2.  Eighteen of 20 classic cases of progeria showed a C-
to-T substitution at codon 608 within exon 11 of LMNA, resulting in a silent gly-to-gly change (G608G).  One 
additional case had a G-to-A substitution just two bases upstream in the same codon.  In all cases, the parents were 
normal, so the misspelling was a new mutation in the child.  Both mutations activated a cryptic splice site within exon 
11, producing a protein product with 50 AA deleted from its C terminus.  This defective lamin A still retains the CAAX 
box, but lacks the site for endoproteolytic cleavage.   
Lamin A is a key component of the nuclear membrane.  It is important to note that in these cases of progeria, many 
cells showed visible abnormalities of the nuclear membrane.  Most cells had strikingly altered nuclear sizes and 
shapes, with envelope interruptions accompanied by chromatin extrusion.  Lamin A levels were at 25% of normal in 
this case.62  The resulting instability of the nuclear membrane is problematic for tissues subjected to intense physical 
stress, such as cardiovascular and musculoskeletal tissues. 
Different mutations in other regions of LMNA lead to Emery-Dreifuss muscular dystrophy type 2, limb girdle 
muscular dystrophy type 1B, Charcot-Marie-Tooth disorder type 2B1, Dunnigan type of familial partial lipodystrophy, 
mandibuloacral dysplasia, and familial form of dilated cardiomyopathy. 
Degradation of the Extracellular Matrix 
 
Matrix metalloproteinases, collagenases, and interleukins are among the proteins secreted in increased amounts by 
senescent dermal fibroblasts.  These extracellular proteins degrade the extracellular matrix architecture, causing 
degradation of connective and other tissues as senescent cell populations increase with age.  Both the collagenous and 
elastic components of dermal connective tissue display degeneration consistent with the overexpression of proteolytic 
activity.   
Alpha1(I) and alpha 2(I) collagen mRNAs are significantly lower in senescent fibroblasts and lowered by the same 
extent, which implies coordinate regulation of the two genes.  Type I collagen is the most abundant in skin.  The 




secretion of type I and III collagens decrease linearly with age, though there is always the same ratio of the two collagen 
types.  There are no age-related variations in cell-associated collagen, however. 
The altered extracellular matrix composition can affect pre-senescent cells via signal transduction at the cell surface.  
It is possible that these signal transduction pathways could alter gene expression in pre-senescent cells, perhaps 
accelerating their time to senescence. 
 
Caloric Restriction Alters Senescence Gene Expression 
 
CRAN stands for caloric restriction with adequate nutrition.  It is the only reproducible method of extending lifespan 
in a wide variety of short-lived species, and lately has also been shown to produce similar metabolic changes in longer-
lived primates.63  Lowering calorie intake essentially lowers the amount of glucose available to mitochondria for 
cellular respiration, and thus it must be here where CRAN’s effects originate. 
Cellular respiration consists of glycolysis in the cytoplasm, and the Krebs cycle and electron transport chain (ETC) 
on the inner mitochondrial membrane.  Glycolysis involves the breakdown of glucose to 2 molecules of pyruvate, and 
the reduction of the electron carrier NAD+ to NADH.  The pyruvate is transported across the mitochondrial membrane 
to where the Krebs cycle occurs.  Here, more NADH are made than in glycolysis.  Finally, the ETC oxidizes the NADH 
back to NAD+, using their electrons to eject protons into the matrix, creating an electrochemical gradient that forces 
them back through the inner mitochondrial membrane.  The protons can only re-enter through ATP synthase 
transmembrane proteins, thus driving the synthesis of ATP which is used by the cell for energy. 
The feature of cellular respiration important to CRAN is NADH.  The NADH molecules go through the electron 
transport chain to ultimately make ATP.  NADH accumulates when the cell is under anaerobic conditions and can’t use 
the ETC to re-oxidize NADH back to NAD+.  When calories are restricted, fewer NADH enter the ETC, which limits 
the oxidation of NADH back to NAD+.64  It turns out that CRAN extends lifespan by lowering the level of NADH in 
the cell, which causes the activation of a special gene. 
This special gene is SIR2, and without it, the lifespan extension of CRAN cannot occur.65  SIR2 which works by 
silencing genes that promote senescence.66  The next section discusses SIR2 in more detail.  It was once thought that the 
increase in NAD+ concentration activates Sir2p, the protein product of SIR2.67  However, Lin et al. (2004) recently 
showed that although the NAD+/NADH ratio did contribute to the activation of Sir2p, it was actually a decrease in 
NADH, not an increase in NAD+, that caused the activation.68  During CRAN, NAD+ levels are high in the 
cytoplasm and nucleus, so NADH levels must be low, thereby activating more SIR2.69  
Not only does CRAN extend lifespan by suppressing senescence, but it also lessens the amount of oxidative damage 
in cells.  Less glucose to burn means fewer free radicals are produced.   
Other Features of Caloric Restriction70 
 
• CRAN increases apoptosis, which generally decreases with age in mitotic tissues.  The basal rate of apoptosis 
in resting tissues eliminates dysfunctional cells. 
• There is a reduction in the disulfide bonds in non-histone chromatin proteins, which promotes more 
transcription compared to normal aging animals. 
• There are higher levels of DNA repair, and much higher levels of gene expression.  Protein synthesis declines 
more slowly with age than it normally does, and in most organs except skeletal muscles and lungs, protein 
synthesis actually increases. 
• Lower body temperature is not the cause of CRAN’s effects, nor is the immune system.  There are fewer 
leukocytes, lymphocytes, and antibodies, but more cell-mediated T-cell killing of tumor cells. 
• The thyroid hormones T4 and T3, which is more potent, increase O2 consumption in almost all tissues, except 
brain, testes, uterus, lymph nodes, spleen, and anterior pituitary.  In CRAN, there is a drop in serum T3 to less 
than half that of control animals, but total body T3 (including that bound to proteins) is the same in both 
groups. 
• There is a 15% reduction in blood glucose in rats.  This could mean less protein cross-linking by glucose, 
which is one possible contributor to aging.  There is less collagen aging by cross-linking. 
• SOD activity does not increase w/ CRAN.  In fact, brain homogenates show less SOD and lysosomal enzymes.  
The antioxidant glutathione increases somewhat.  Catalase increases very dramatically; it typically falls w/ age. 
• The likely causes of CRAN are selective upregulation in repair and protective processes, increased metabolic 
efficiency, decreased production of damaging agents, and signals to the neuroendocrine network, particularly 
the hypothalamus.  The causative events of CRAN likely take place in proliferative systems (dividing cells).  




Also, reduced glycation (protein cross-linking by sugars) and reduced free radical generation could be other 
contributors to CRAN’s effects.
 
CRAN Decreases Senescence Gene Transcription via SIR2 
 
What is SIR2?  
 
SIR2 (silent information regulator) is a histone deacetylase necessary for transcriptional silencing at the telomeres.  It 
functions in a complex with SIR3 and SIR4.  These three genes along with UTH4 determine lifespan in yeast.  If these 
genes are deleted, yeast lifespan is significantly shortened.  If these genes are overexpressed, the lifespan extends way 
beyond wild-type.  The gene products encoded by SIR2, 3, and 4 move from the telomeres to the nucleolus; it is this action 
that promotes longevity.   
Sir2p (the protein encoded by SIR2), along with Sir1, 3, 4, and Rap, deacetylates the N-terminal tails of histones H3 and 
H4 at telomeres, one of the 3 deacetylation sites in yeast.71  They extend lifespan by silencing genes.72  When the acetyl 
groups are moved from the histone tails, they become positively charged and interact more strongly with negatively 
charged DNA molecules.  The DNA/histone complexes become more tightly packed, which cause the chromatin in that 
region to become more tightly packed, which causes transcriptional repression.73  Since genes near the ends of telomeres 
are likely inactivated due to the tight packing of telomeric chromatin, this supports the idea that genes at the ends of 
chromosomes are responsible for promoting senescence.  
SIR2 also silences and represses mitotic recombination of rDNA by establishing a more closed chromatin structure 
there.74  By suppressing rDNA recombination, SIR2 stifles the production of extrachromosomal rDNA loops that get 
replicated to toxic levels, which would otherwise trigger cellular senescence.75  
A SIR2 mutation can shorten lifespan by 50% because the mutants can’t suppress the generation of ERCs.76  ERC 
accumulation in yeast is a cause of aging.77  Sir2p localizes to the rDNA and represses homologous recombination, which is 






SIR2 also has a weak ADP-ribosyltransferase activity.79  ADP-ribosylation is associated with the repair of damaged 
DNA.  DNA damage causes the rapid induction of polyadenosine diphosphate ribose synthesis (ADP-ribosylation) in 
nuclei, which results in the extensive depletion of cellular NADH pools.  SIR2, which requires low NADH, is likely 
activated.  This would be appropriate since Sir2- is also known to function in dsDNA break repair.80  
 
The Link Between SIR2 and Senescence 
 
Histone deacetylase inhibitors such as SIR2, which decondense 
chromatin and activate the transcription of some genes, have 
already been shown to induce a senescence-like state in human 
fibroblasts.81 82 This suggests that the conversion of some 
heterochromatin (condensed, inactive DNA) to euchromatin 
(actively transcribed DNA) may be a feature of replicative 
senescence.  
The HDAC inhibitor sodium butyrate rapidly induces a 
senescent-like phenotype in human fibroblasts83 and reduced levels 
of Sir2, a protein with HDAC activity, causes accelerated aging in 
yeast cells.84  
From Caroline Lindsay 
SIR2 Protein: An 
Important Link Between 
Aging and Metabolism 
http://sq.ucsd.edu/sq1_
caroline_lindsay.pdf 




In the presence of HDAC inhibitors, fibroblasts senesce after several population doublings.85  This state resembles 
replicative senescence in terms of morphology, saturation density, and cell cycle distribution, including the accumulation of 
hypophosphorylated RB and induction of CDKI p21Waf-1 protein.86  In yeast cells, overexpression of Sir2 extends life span 
in a manner dependent on NAD-dependent HDAC activity.87  It is presently unknown whether mouse or human Sir2 
homologues have similar activity.  
 
SIR2 and the Insulin-Like Signaling Pathway 
 
Increasing the expression of the sir-2.1 gene extended the C. elegans lifespan, as overexpression of SIR2 did in yeast.88  
In C. elegans, lifespan is partially controlled by the insulin-like signaling pathway.89  Insulin signals the cell to produce 
more glucose, stimulating more cellular respiration and leading to more NADH production.  Insulin is important in 
regulating the NAD+/NADH ratio needed for both Sir2p and sir-2.1 activity.  The sir-2.1-dependent lifespan extension is 




There is much more knowledge about the aging process than has been included here, since this paper was meant only to 
be an overview of what we currently know.  However, it is a good start for those who might not have heard of much 
credible research on aging, as well as for biomedical researchers, who may want to contribute their research and experience 
toward the goal of extending human lifespan.   
Reaching this goal will require collaboration across many different fields of biology and medicine, including but not 
limited to genetics and genomics, molecular and cell biology, biophysics, structural biology, cancer biology, and 
biochemistry.  It will also require the adaptation of current technologies toward new uses.  A brief proposal of how 
available technology might be adapted toward this goal is discussed below. 
Extending Lifespan with Gene Therapy 
 
The first technology we should consider in reaching our goal of extending human lifespan is gene therapy.  In particular, 
adenoviral gene therapy is a reliable technology that can be put to work today.  Past methods of gene therapy have largely 
been ineffective and in some cases have resulted in severe side effects.  However, modern adenoviral approaches are being 
worked on at many universities, and have been shown to be safe and reliable in human cells.   
Adenoviral vectors can insert genes into a particular spot within the genome without triggering the immune system or 
causing other harm.  With our knowledge of DNA structure, we will likely want to have new genes inserted into stretches 
of DNA that are usually in the form of actively transcribed euchromatin rather than inactive, condensed heterochromatin.  
These new genes will either be repressors of senescence, or promoters of long lifespan by decreasing oxidative damage 
and/or stabilizing nuclear structure.  We will likely want to insert genes that do both, to derive maximum benefit.   
Success in gene therapy for aging must be shown in lower eukaryotes before any steps can be made to treat humans.  
Thus, it is important to start early with attempts in yeast, C. elegans, fruit flies, and mice.  A mouse genetically altered to 
have longer lifespan would especially attract interest from more researchers since it is a species not too distantly related to 
our own.  Such a mouse would certainly stimulate a push for trials in humans. 
The Technological Challenge of Treating Older Humans 
 
It is the older population who could stand to benefit the most from such lifespan-extending gene therapy.  However, an 
obstacle unique to the elderly is the structural and genetic deterioration already present due to the high concentration of 
senescent cells.  Gene therapy against aging would be most effective if done to prevent senescence in the first place; thus 
younger people would stand to benefit more from this treatment.  It will not be possible to stop the senescence process in 
the elderly, whose cells have mostly already undergone senescence.  To treat the elderly, who have accumulated much 
damage to their cells over the years, senescent cell populations would need to be culled and replaced by healthier, pre-
senescent cells that have been stimulated to divide.   
One piece of the technology to do this can be found in labs where new tissues have been stimulated to grow from adult 
stem cells.  These techniques can be used to grow new tissues if a healthy cell from the body can be found.  Another piece 
can be derived from cancer research, where researchers have targeted genes unique to cancer (e.g. telomerase)91.  Senescent 
cells display an altered expression of proteins on their cell surface, making them targetable by both viral vectors and the 
body’s own immune system.  Viral vectors could be used to insert genes that would lead to apoptosis of senescent cells, 




while anti-senescent cell antibodies could be used to dispatch these cells.  The death and removal of senescent cells must 
take place slowly, and be balanced with the regrowing of new tissue to avoid any adverse effects caused by rapid cell death 
and renewal. 
A Call to Action 
 
While seemingly immortal cells continue to flourish, dividing fruitfully in their scattered laboratory Petri dishes, we 
capable human beings are all destined to die without exceeding today’s maximum lifespan.  This is the case only because 
little initiative has been taken to try and extend human life.   
The technology currently exists to enable people to enjoy extra healthful decades of life.  We could have more time to 
experience life, learn from it, teach others what we have learned, and prepare for its conclusion.  If given extra years to live, 
researchers may find ways of extending lives even further, just as Einstein could have figured out a quantum theory of 
gravity if he did not run out of time.  Humanity will very likely continue to be resourceful in finding technological solutions 
to problems, but we may not live long enough to see these solutions.   
It has always been difficult to invest time and resources into something whose results may never be seen, although 
people have been doing this throughout history.  We plant trees in our old age, knowing we will never sit beneath their 
bountiful shade.  We teach our children to be good citizens so they can take over things after we are gone.  We set aside 
forests and preserves so that our posterity will have some knowledge of how beautiful the world can be without human 
interference.  In the same spirit, we can choose to pour funding into lifespan-extending research.  Those who have amassed 
great wealth can choose to spend more of it on research that could lengthen and enrich the quality of their aging lives.   
In the end, perhaps our own years may not be lengthened, but those of our children might.  It says much about the 
character of a person willing to do this, that he or she really cares about our future.   
 




Academic Labs Conducting Research on Aging 
 
The following are labs where research on the fundamentals of aging is being done.  It was a list I compiled in search of 
good graduate labs and programs in this field.  If you are interested in studying solutions to aging in graduate school, 
inquire with one or more of the professors below.  Unfortunately it is only a list of American labs, though there is booming 
international research in the UK and other countries.  I will try to compile an international list of labs soon, to support 
broader collaboration between countries on the issue of aging.  Aging, of course, is a disease with no national boundaries.  
















telomerase; investigate how cancer cells acquire the ability to 





uncover novel functions for reversible protein acetylation in signal 





regulation of complex cellular processes, including entry into 






cell cycle control, in particular how it interacts with control of cell 





heat shock transcription factors, genome-wide stress responses, 













elucidate the signaling pathways (Wnt) that regulate 





understand how ion channels work at the molecular level; how 





E2F transcription factor, Myc oncoproteins, Myc and Ras signaling 
pathways together with the Rb/E2F pathway in control of cell 
proliferation and fate 
Steven Haase 
http://fds.duke.edu/db/aas/Biology/faculty/shaase 
Control of cell cycle, DNA replication, and centrosome duplication 
in budding yeast  
 






Elucidation of the pathogenesis of human progerias (diseases of 














Study of aging as it affects the lens epithelium and bone 
(osteoblasts); the mechanism(s) and prevention of age related 










Study of senes-associated genes (including retinoic acid receptor 
beta) that contribute to the prevention/treatment of breast cancer; 





Oxygen free radicals and glutathione metabolism in environmental 
disease and aging  
Stephen Plymate 







Insulin-like growth factor (IGF) receptor, senescence-associated 










biochemical and molecular basis for species and interindividual 
differences in response to chemical carcinogens 
 








experimental, theoretical, and computational approaches to study 
genetic mechanisms underlying the biology of aging; CRAN and 
environmental approaches 






Telomeres in yeast and humans 
Si Yi Chen 
(713) 798-1236  
sychen@bcm.tmc.edu  
http://www.bcm.edu/cmb/applicants/facres/faculty_res_chen.htm 
Gene therapy for cancer and AIDS research 
Lawrence Donehower 










definition of the molecular basis for longevity in three different 






Hematopoietic stem cells 
Anil Jaiswal 




determination of molecular mechanisms of coordinated activation 






regulation of aging and cancer of human melanocytes 




(210) 562-5069  
SMITHO@UTHSCSA.EDU  
http://www.uthscsa.edu/csb/faculty/pereira.html 
replicative senescence, immortalization, complementation groups, 
chromatin remodeling, transcriptional regulation  
Pamela L. Larsen 
(210) 567-0608  
larsenp@uthscsa.edu  
http://www.uthscsa.edu/csb/faculty/larsen.html 
Molecular genetics, aging, development, expression analysis, 
functional genomics, genetic and environmental interactions and 
C. elegans physiology.  




telomerase, aging, Werner syndrome, cell regulation  














Aging, transgenic mice, knockout mice, oxidative stress, DNA 
repair  




Apoptosis, mitochondria, cancer, aging, optical imaging  
 










Yeast studies of regulation of genome stability, telomere length 




Tumor Suppressor Genes, Genetics of Cancer and Aging 
 
Virginia Commonwealth University 
 
Lynne W. Elmore 
(804) 628-0256  
lelmore@vcu.edu 
http://www.pathology.vcu.edu/research/holt_el/elmore.html 
Molecular Mechanisms of Aging & Cancer 
Shawn Edan Holt  
(804) 827-0458  
seholt@vcu.edu  






Molecular Mechanisms of Aging and Cancer Initiation and 
Progression  
Joy Ware  
(804) 828-9746  
jlware@vcu.edu  
http://www.pathology.vcu.edu/research/funcgeno/ware.html 
Functional genomics, cancer 
Colleen Jackson-Cook 
804 828 9632 ext 118  
jacksonc@hsc.vcu.edu  
http://www.vipbg.vcu.edu/hg/dr/CJACKSON.shtml 
Cancer, aneuploidy, Down's syndrome, chromosomal 
abnormalities 
 














Molecular and Genetic Analysis of Leaf Greening and Senescence 
 








Human genetics; comparative DNA sequence analysis; behavioral 




Oxygen sensing and control of gene expression; mitochondrial 
biogenesis in the yeast Saccharomyces cerevisiae; oxidative stress 
and aging 
 
Wake Forest University 
 
Steven Akman 
(336) 716-0231  
http://www.wfubmc.edu/molecular_genetics/faculty/akman_steven
.htm 




Analysis of human diseases using DNA polymorphisms; emphasis 















Skeletal muscle atrophy 




mechanisms by which the organization of components of the cell 
nucleus directs the expression and stability of the genome 
 
University of Colorado Health Sciences Center 
 
Jerome Schaack - Molec Bio 
jerry.schaack@uchsc.edu 
http://www.uchsc.edu/molbio/jschaack.html 
development of vectors (adenovirus) for gene therapy 
Mair E. Churchhill (F) - Molec Bio 
Mair.Churchill@uchsc.edu 
http://www.uchsc.edu/molbio/mchurchill.html 
Structural Analysis of Gene-Regulatory Protein Complexes, DNA 




cellular responses to DNA damage and envirionmental stress by 





chromatin assembly and remodeling 
 











Glutathione S-Transferases; Protein Evolution; Computational 
Biology  
 







role of stress proteins (heat shock proteins) in cytoprotection and 
carcinogenesis 
 




NIKS immortal cell line 
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